Telix Pharmaceuticals, INSERM and ARRONAX Enter into Translational Research Partnership
15 avr. 2018 20h15 HE
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia and NANTES, France, April 16, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX:TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company focused on...